Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06962033 · ClinicalTrials.gov registry record · NA
PRIDE III Prison Interventions and HIV Prevention Collaboration
A NA study of HIV and Opioid Use, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 5
- Study locations
NCT06962033 is a NA study of HIV and Opioid Use that is actively recruiting participants, run by Yale University. The registered enrollment target is 300 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (32% lower). The trial reports 5 study locations across 2 states.
The verdict
NCT06962033, a NA study of HIV and Opioid Use, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 5
- Study locations
Study Summary
The primary objective of this research project is to identify barriers to scale-up of Opioid Agonist Therapy (OAT) in the justice systems (prisons and probation) in Tajikistan, Kyrgyzstan, Moldova, and Georgia, and establish a NIATx learning collaborative to scale-up OAT, and analyze scale-up utilizing latent class growth analyses in people who inject drugs (PWID).
Conditions Studied
Interventions
- BEHAVIORAL Opioid Agonist Therapy
Study Locations (5)
Other
- Alternative Georgia - Tbilisi
- AIDS Foundation East-West (AFEW) - Bishkek
- NGO AFI - Chisinau
- Institute for International Health and Education (IIHE) - Dushanbe
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-11-05 |
| Est. Completion | 2028-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06962033
The ClinicalTrials.gov registry entry for NCT06962033 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (32% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Opioid Agonist Therapy is the first listed.
NCT06962033 reports 5 study locations spanning 2 distinct geographic areas - top geographies include Other, Connecticut.
Frequently Asked Questions
What is clinical trial NCT06962033 about?
NCT06962033 is a clinical study titled "PRIDE III Prison Interventions and HIV Prevention Collaboration". The primary objective of this research project is to identify barriers to scale-up of Opioid Agonist Therapy (OAT) in the justice systems (prisons and probation) in Tajikistan, Kyrgyzstan, Moldova, and Georgia, and establish a NIATx learning collaborative to scale-up OAT, and analyze scale-up utiliz...
What is the current status of trial NCT06962033?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-11-05. Estimated completion is 2028-12.
What conditions does trial NCT06962033 study?
This clinical trial studies the following conditions: HIV, Opioid Use.
What interventions are being tested in trial NCT06962033?
The interventions under investigation include: Opioid Agonist Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06962033?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06962033 being conducted?
This trial has 5 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.